LSA
AMED

Leonteq Securities AG’s Amedisys AMED Stock Holding History

Leonteq Securities AG’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$27.4K – 1195
2023
Q2 		$27.4K Hold
300
– – ﹤0.01% 926
2023
Q1 		$22.1K Hold
300
– – ﹤0.01% 921
2022
Q4 		$25.1K Hold
300
– – ﹤0.01% 940
2022
Q3 		$29K Hold
300
– – ﹤0.01% 912
2022
Q2 		$31.5K Sell
300
-324
-52% -$41.4K ﹤0.01% 914
2022
Q1 		$108K Hold
624
– – ﹤0.01% 721
2021
Q4 		$101K Buy
624
+271
+77% +$43.6K ﹤0.01% 773
2021
Q3 		$52.6K Sell
353
-4
-1% -$832 ﹤0.01% 839
2021
Q2 		$87.4K Buy
+357
New +$93.7K 0.01% 743

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Leonteq Securities AG's AMED Position: Q3 2023 in Review

Leonteq Securities AG sold out of Amedisys (AMED) in Q3 2023, closing a stake of 300 shares — an estimated $27.4K sold.

Leonteq Securities AG first reported a position in AMED in Q2 2021 and held it in 9 quarters. The position peaked at $108K in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Leonteq Securities AG reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 300 Amedisys shares in Q3 2023, an estimated $27.4K.
  • Leonteq Securities AG first reported a position in Amedisys in Q2 2021 and held it in 9 quarters.
  • Leonteq Securities AG's Amedisys position peaked at $108K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.